September 25th, 2027.
The sun had just risen over New York City, but the headquarters of Aegis Pharmaceuticals was already buzzing with activity. Reporters from CNN, The New York Times, and other major media outlets had gathered outside, eager to cover the latest developments in the high-stakes saga between Aegis Pharmaceuticals and Reyes Corporation.
Cameras flashed and microphones were thrust forward as Elena Skies, CEO of Aegis Pharmaceuticals, emerged from the building. She paused at the entrance, her composed demeanor betraying none of the stress she had been under in recent weeks.
"Ms. Skies, over here!" shouted a reporter from CNN. "What do you have to say about the recent accusations against Aegis Pharmaceuticals?"
